PharmaForceIQ

MIAMI – November 02, 2026 -- Brand and condition websites account for just 17% of AI-answer citations on average, according to PharmaForceIQ audits behind the launch of Share of Answer, a new module in its Optichannel 360 platform for biopharma companies.

Audits find retired webpages and superseded FDA labeling in AI answers

The audits identified citations to hundreds of retired webpages. In one analysis, AI-generated responses quoted superseded FDA-approved labeling in nearly 250 answers.

Abbreviations also caused errors. In a rare disease analysis, AI engines identified the condition correctly when prompted with its full name, but more than half of the answers failed to identify it when an abbreviation was used.